1. Home
  2. FCNCA vs NTRA Comparison

FCNCA vs NTRA Comparison

Compare FCNCA & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCNCA
  • NTRA
  • Stock Information
  • Founded
  • FCNCA 1898
  • NTRA 2003
  • Country
  • FCNCA United States
  • NTRA United States
  • Employees
  • FCNCA N/A
  • NTRA N/A
  • Industry
  • FCNCA Major Banks
  • NTRA Medical Specialities
  • Sector
  • FCNCA Finance
  • NTRA Health Care
  • Exchange
  • FCNCA Nasdaq
  • NTRA Nasdaq
  • Market Cap
  • FCNCA 22.6B
  • NTRA 27.0B
  • IPO Year
  • FCNCA N/A
  • NTRA 2015
  • Fundamental
  • Price
  • FCNCA $1,823.91
  • NTRA $209.87
  • Analyst Decision
  • FCNCA Buy
  • NTRA Strong Buy
  • Analyst Count
  • FCNCA 10
  • NTRA 18
  • Target Price
  • FCNCA $2,139.00
  • NTRA $211.44
  • AVG Volume (30 Days)
  • FCNCA 110.5K
  • NTRA 1.3M
  • Earning Date
  • FCNCA 10-23-2025
  • NTRA 11-06-2025
  • Dividend Yield
  • FCNCA 0.46%
  • NTRA N/A
  • EPS Growth
  • FCNCA N/A
  • NTRA N/A
  • EPS
  • FCNCA 169.29
  • NTRA N/A
  • Revenue
  • FCNCA $8,897,000,000.00
  • NTRA $2,116,676,000.00
  • Revenue This Year
  • FCNCA $2.82
  • NTRA $25.70
  • Revenue Next Year
  • FCNCA N/A
  • NTRA $15.42
  • P/E Ratio
  • FCNCA $10.74
  • NTRA N/A
  • Revenue Growth
  • FCNCA N/A
  • NTRA 38.17
  • 52 Week Low
  • FCNCA $1,473.62
  • NTRA $125.38
  • 52 Week High
  • FCNCA $2,412.93
  • NTRA $210.90
  • Technical
  • Relative Strength Index (RSI)
  • FCNCA 55.28
  • NTRA 78.04
  • Support Level
  • FCNCA $1,805.75
  • NTRA $182.20
  • Resistance Level
  • FCNCA $1,836.40
  • NTRA $210.90
  • Average True Range (ATR)
  • FCNCA 41.74
  • NTRA 7.65
  • MACD
  • FCNCA 8.51
  • NTRA 0.81
  • Stochastic Oscillator
  • FCNCA 76.25
  • NTRA 93.15

About FCNCA First Citizens BancShares Inc.

First Citizens BancShares Inc is the bank holding company of First Citizens Bank and Trust Company. The company's segments include the General Bank, the Commercial Bank, SVB Commercial, and Rail. The General Bank segment delivers products and services to consumers and businesses through its extensive network of branches and various digital channels. The Commercial Bank segment provides financial services, including lending, leasing, and advisory, to small and mid-market businesses across various industries. The SVB Commercial provides financial services to innovators, investors, and venture firms. The Rail segment provides tailored leasing and financing for railcars and locomotives across North America. It generates the majority of its revenue from the General Banking segment.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: